Literature DB >> 17171794

Construction of a fusion protein expression vector MK-EGFP and its subcellular localization in different carcinoma cell lines.

Li-Cheng Dai1, Di-Yong Xu, Xing Yao, Li-Shan Min, Ning Zhao, Bo-Ying Xu, Zheng-Ping Xu, Yong-Liang Lu.   

Abstract

AIM: To construct an expression plasmid encoding human wild-type midkine (MK) and enhanced green fluorescence protein (EGFP) fusion protein (MK-EGFP), and to analyze the subcellular localization of MK in different carcinoma cell lines.
METHODS: Two kinds of MK coding sequences with or without signal peptide were cloned into plasmid pEGFP-N2, and the recombinant plasmids constructed were introduced into HepG2, MCF7 and DU145 cells, respectively, by transfection. With the help of laser scanning confocal microscopy, the expression and subcellular localization of MK-GFP fusion protein could be detected.
RESULTS: Compared with the GFP control, in which fluorescence was detected diffusely over the entire cell body except in the nucleolus, both kinds of fusion protein MK-GFP were localized exclusively to the nucleus and accumulated in the nucleolus in the three kinds of cancer cell lines.
CONCLUSION: This study reveals the specific nucleolar translocation independent of signal peptide, which may be involved in the mechanism that MK works. It provides valuable evidence for further study on the functions of MK in nucleus and its possible mechanisms, in which ribosomal RNA transcription and ribosome assembly are involved.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17171794      PMCID: PMC4088047          DOI: 10.3748/wjg.v12.i47.7649

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  26 in total

1.  An angiogenic role for the neurokines midkine and pleiotrophin in tumorigenesis.

Authors:  R Choudhuri; H T Zhang; S Donnini; M Ziche; R Bicknell
Journal:  Cancer Res       Date:  1997-05-01       Impact factor: 12.701

2.  Proteasomal degradation of the nuclear targeting growth factor midkine.

Authors:  Noriyuki Suzuki; Yoshihisa Shibata; Takeshi Urano; Toyoaki Murohara; Takashi Muramatsu; Kenji Kadomatsu
Journal:  J Biol Chem       Date:  2004-02-17       Impact factor: 5.157

3.  Inhibition of NF-kappa B activity induces apoptosis in murine hepatocytes.

Authors:  R E Bellas; M J FitzGerald; N Fausto; G E Sonenshein
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

4.  The angiogenic factor midkine is expressed in bladder cancer, and overexpression correlates with a poor outcome in patients with invasive cancers.

Authors:  T O'Brien; D Cranston; S Fuggle; R Bicknell; A L Harris
Journal:  Cancer Res       Date:  1996-06-01       Impact factor: 12.701

5.  Comparison of biological phenotypes according to midkine expression in gastric cancer cells and their autocrine activities could be modulated by pentosan polysulfate.

Authors:  S Y Rha; S H Noh; H J Kwak; A Wellstein; J H Kim; J K Roh; J S Min; B S Kim; H C Chung
Journal:  Cancer Lett       Date:  1997-09-16       Impact factor: 8.679

Review 6.  Nuclear targeting by growth factors, cytokines, and their receptors: a role in signaling?

Authors:  D A Jans; G Hassan
Journal:  Bioessays       Date:  1998-05       Impact factor: 4.345

7.  Purification of recombinant midkine and examination of its biological activities: functional comparison of new heparin binding factors.

Authors:  H Muramatsu; T Muramatsu
Journal:  Biochem Biophys Res Commun       Date:  1991-06-14       Impact factor: 3.575

8.  Midkine and pleiotrophin expression in normal and malignant breast tissue.

Authors:  R I Garver; D M Radford; H Donis-Keller; M R Wick; P G Milner
Journal:  Cancer       Date:  1994-09-01       Impact factor: 6.860

9.  Midkine induces the transformation of NIH3T3 cells.

Authors:  K Kadomatsu; M Hagihara; S Akhter; Q W Fan; H Muramatsu; T Muramatsu
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

10.  Increased midkine gene expression in human gastrointestinal cancers.

Authors:  K Aridome; J Tsutsui; S Takao; K Kadomatsu; M Ozawa; T Aikou; T Muramatsu
Journal:  Jpn J Cancer Res       Date:  1995-07
View more
  2 in total

1.  Inducible nitric oxide synthase drives mTOR pathway activation and proliferation of human melanoma by reversible nitrosylation of TSC2.

Authors:  Esther Lopez-Rivera; Padmini Jayaraman; Falguni Parikh; Michael A Davies; Suhendan Ekmekcioglu; Sudeh Izadmehr; Denái R Milton; Jerry E Chipuk; Elizabeth A Grimm; Yeriel Estrada; Julio Aguirre-Ghiso; Andrew G Sikora
Journal:  Cancer Res       Date:  2014-01-07       Impact factor: 12.701

2.  Midkine accumulated in nucleolus of HepG2 cells involved in rRNA transcription.

Authors:  Li-Cheng Dai; Jian-Zhong Shao; Li-Shan Min; Yong-Tao Xiao; Li-Xin Xiang; Zhi-Hong Ma
Journal:  World J Gastroenterol       Date:  2008-10-28       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.